Elisa Gremese Selected Research

COVID-19

12/2023	COVID-19 illness: Different comorbidities may require different immunological therapeutic targets.
11/2023	Extension of Lung Damage at Chest Computed Tomography in Severely Ill COVID-19 Patients Treated with Interleukin-6 Receptor Blockers Correlates with Inflammatory Cytokines Production and Prognosis.
4/2023	Use of First-Line Oral Analgesics during and after COVID-19: Results from a Survey on a Sample of Italian 696 COVID-19 Survivors with Post-Acute Symptoms.
4/2023	Ecology and Machine Learning-Based Classification Models of Gut Microbiota and Inflammatory Markers May Evaluate the Effects of Probiotic Supplementation in Patients Recently Recovered from COVID-19.
3/2023	Effects of l-Arginine Plus Vitamin C Supplementation on l-Arginine Metabolism in Adults with Long COVID: Secondary Analysis of a Randomized Clinical Trial.
1/2022	Immune-Guided Therapy of COVID-19.
10/2021	Compassionate use of anti-IL6 receptor antibodies in critically ill patients with acute respiratory distress syndrome due to SARS-CoV-2.
1/2021	RAASI, NSAIDs, antidiabetics, and anticoagulants: More data needed to be labeled as harmful or neutral in SARS-CoV-2 infection.
1/2021	Nailfold capillaroscopy findings in patients with coronavirus disease 2019: Broadening the spectrum of COVID-19 microvascular involvement.
1/2021	COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elisa Gremese Research Topics

Disease

66	Rheumatoid Arthritis 03/2024 - 06/2004
22	Arthritis (Polyarthritis) 01/2023 - 11/2010
21	Psoriatic Arthritis 03/2024 - 11/2015
18	Inflammation (Inflammations) 01/2023 - 06/2004
13	COVID-19 12/2023 - 09/2020
12	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2023 - 11/2004
11	Necrosis 10/2023 - 07/2011
10	Infections 12/2023 - 06/2004
8	Axial Spondyloarthritis 03/2024 - 11/2015
7	Rheumatic Diseases (Rheumatism) 11/2023 - 06/2010
6	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020 - 01/2018
5	Adult-Onset Still's Disease 07/2020 - 01/2017
4	Obesity 12/2023 - 01/2013
4	Hypertension (High Blood Pressure) 12/2023 - 01/2021
4	Joint Diseases (Joint Disease) 01/2023 - 11/2016
4	Systemic Scleroderma (Systemic Sclerosis) 01/2023 - 07/2018
4	Autoimmune Diseases (Autoimmune Disease) 05/2021 - 01/2018
4	Neoplasms (Cancer) 07/2020 - 01/2018
4	Overweight 08/2019 - 05/2014
3	Heart Failure 12/2023 - 01/2019
3	Lupus Nephritis 11/2021 - 01/2016
3	Synovitis 01/2021 - 07/2017
3	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 01/2020 - 01/2017
3	Giant Cell Arteritis (Horton Disease) 01/2020 - 04/2013
3	Vasculitis (Vasculitides) 01/2020 - 11/2016
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019 - 07/2017
2	Pneumonia (Pneumonitis) 12/2023 - 10/2020
2	Arthralgia (Joint Pain) 04/2023 - 05/2021
2	Post-Acute COVID-19 Syndrome 03/2023 - 11/2022
2	Sclerosis 01/2023 - 11/2019
2	Fatigue 11/2022 - 11/2014
2	Connective Tissue Diseases (Connective Tissue Disease) 09/2020 - 12/2018
2	Pulmonary Arterial Hypertension 05/2020 - 01/2019
2	Ankylosing Spondylitis 01/2020 - 03/2007
2	Spondylarthropathies 07/2019 - 01/2019
2	Pain (Aches) 01/2019 - 09/2017
2	Weight Loss (Weight Reduction) 01/2018 - 07/2016
2	Body Weight (Weight, Body) 01/2018 - 05/2014
2	Atherosclerosis 08/2011 - 01/2011

Drug/Important Bio-Agent (IBA)

18	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2011
14	Antirheumatic Agents (DMARD)IBA 01/2024 - 12/2012
12	Tumor Necrosis Factor InhibitorsIBA 11/2023 - 05/2014
12	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2020 - 06/2004
11	Methotrexate (Mexate)FDA LinkGeneric 01/2023 - 07/2011
8	CytokinesIBA 12/2023 - 09/2011
8	Etanercept (Enbrel)FDA Link 11/2023 - 06/2012
8	Ustekinumab (CNTO 1275)FDA Link 10/2023 - 01/2018
8	SteroidsIBA 05/2021 - 11/2006
7	Rituximab (Mabthera)FDA Link 11/2023 - 12/2014
7	ametantrone (HAQ)IBA 10/2023 - 01/2014
6	C-Reactive ProteinIBA 01/2023 - 01/2011
5	GlucocorticoidsIBA 11/2023 - 01/2017
5	Interleukin-12 (IL 12)IBA 08/2023 - 11/2021
5	Abatacept (Orencia)FDA Link 07/2022 - 09/2017
5	AntibodiesIBA 10/2021 - 06/2010
5	AutoantibodiesIBA 01/2019 - 06/2004
5	Infliximab (Remicade)FDA Link 01/2018 - 03/2007
5	Adalimumab (Humira)FDA Link 07/2017 - 06/2012
4	Interleukin-6 (Interleukin 6)IBA 12/2023 - 11/2010
4	InterleukinsIBA 11/2023 - 07/2006
4	belimumabIBA 04/2023 - 01/2020
4	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2023 - 11/2015
4	AutoantigensIBA 06/2022 - 06/2004
4	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2020 - 06/2017
3	golimumab FDA Link 03/2024 - 01/2021
3	Monoclonal AntibodiesIBA 12/2023 - 10/2021
3	Proteins (Proteins, Gene)FDA Link 11/2023 - 09/2011
3	tocilizumab (atlizumab)FDA Link 11/2023 - 01/2020
3	Antimalarials (Antimalarial Agents)IBA 06/2022 - 09/2020
3	Interleukin-1 (Interleukin 1)IBA 01/2020 - 12/2012
3	AntigensIBA 04/2019 - 11/2010
3	AdipokinesIBA 07/2016 - 08/2011
2	InflammasomesIBA 12/2023 - 01/2023
2	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2023 - 03/2016
2	LipidsIBA 11/2023 - 01/2020
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 11/2023 - 10/2021
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 03/2023 - 11/2022
2	Arginine (L-Arginine)FDA Link 03/2023 - 11/2022
2	CitrullineIBA 03/2023 - 01/2019
2	Interleukin-17 (Interleukin 17)IBA 01/2023 - 12/2022
2	Sulfasalazine (Azulfidine)FDA LinkGeneric 06/2022 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 06/2022 - 05/2021
2	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2022 - 01/2020
2	sarilumabIBA 10/2021 - 10/2020
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 05/2021 - 01/2021
2	CollagenIBA 01/2021 - 12/2015
2	16S Ribosomal RNAIBA 01/2021 - 05/2020
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2019 - 04/2019
2	vedolizumabIBA 11/2019 - 01/2019
2	HLA-DRB1*04 antigenIBA 04/2019 - 12/2015
2	Hormones (Hormone)IBA 02/2019 - 01/2019
2	Rheumatoid FactorIBA 01/2019 - 09/2011
2	Immunoglobulin M (IgM)IBA 01/2018 - 09/2011
2	Immunoglobulin A (IgA)IBA 01/2018 - 09/2011
2	amsonic acid (DAS)IBA 07/2017 - 01/2009
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2016 - 11/2006

Therapy/Procedure

40	Therapeutics 01/2024 - 06/2004
5	Biological Therapy 11/2023 - 01/2009
2	Precision Medicine 01/2023 - 01/2013
2	Immunotherapy 01/2020 - 12/2019